Elevated triglyceride-rich lipoproteins may causally contribute to residual cardiovascular risk in patients with coronary artery disease despite optimal LDL lowering.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Alan R. Tall (2017) conducted a review in Coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: